Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-21
DOI
10.3389/fimmu.2018.02009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
- (2018) G.H. Callejas et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
- (2018) Fernanda F. Peres et al. Frontiers in Pharmacology
- The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law
- (2017) Alice Mead EPILEPSY & BEHAVIOR
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative
- (2017) Nicole R. Silva et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- (2017) Marco Aurélio Mori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
- (2017) Raquel A. Do Val-da Silva et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons
- (2017) Shanshan Sun et al. Redox Biology
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- ICD and DSM: neuroplasticity and staging are still missing
- (2016) Stefano Pallanti CNS SPECTRUMS
- Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test
- (2016) I. Linares et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
- (2016) Mahshid Hosseinzadeh et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Prohedonic Effect of Cannabidiol in a Rat Model of Depression
- (2016) Gal Shoval et al. NEUROPSYCHOBIOLOGY
- Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
- (2016) Aviva Breuer et al. PLoS One
- Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
- (2016) Angélica Pupin Schiavon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
- (2016) F.F. Peres et al. SCHIZOPHRENIA RESEARCH
- Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
- (2016) José A. S. Crippa et al. Frontiers in Pharmacology
- Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
- (2016) Chenchen Song et al. Frontiers in Pharmacology
- Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
- (2015) A.L.Z. Marinho et al. BEHAVIOURAL BRAIN RESEARCH
- Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
- (2015) Cristina A.J. Stern et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
- (2015) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
- (2015) Francieli Vuolo et al. MEDIATORS OF INFLAMMATION
- Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release
- (2015) Pedro H. Gobira et al. NEUROTOXICOLOGY
- Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
- (2015) Luiza Reali Nazario et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
- (2015) J. F. C. Pedrazzi et al. PSYCHOPHARMACOLOGY
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
- (2015) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia
- (2015) Cristiano Chaves et al. SCHIZOPHRENIA RESEARCH
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Molecular network of neuronal autophagy in the pathophysiology and treatment of depression
- (2015) Jack Jia et al. Neuroscience Bulletin
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
- (2014) Alexandre Schier et al. CNS & Neurological Disorders-Drug Targets
- Neuroimaging Studies of Acute Effects of THC and CBD in Humans and Animals: a Systematic Review
- (2014) A. Batalla et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury
- (2014) A. Ribeiro et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins
- (2014) Patrícia Schönhofen et al. MOLECULAR NEUROBIOLOGY
- Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain
- (2014) Samira S. Valvassori et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
- (2013) Emelie Janefjord et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
- (2013) M.V. Fogaça et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
- (2013) Mirella Nardo et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Dynamic Brain: Neuroplasticity and Mental Health
- (2013) Jill L. Kays et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)
- (2013) André Twardowschy et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
- (2013) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
- (2013) Vanessa Kappel da Silva et al. MOLECULAR NEUROBIOLOGY
- Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
- (2013) M. Ruth Pazos et al. NEUROPHARMACOLOGY
- Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
- (2013) Albert Batalla et al. PLoS One
- Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
- (2013) Marta Solinas et al. PLoS One
- Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice
- (2013) Felipe V. Gomes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
- (2012) Sagnik Bhattacharyya ARCHIVES OF GENERAL PSYCHIATRY
- A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
- (2012) Antonio Waldo Zuardi et al. CURRENT PHARMACEUTICAL DESIGN
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
- (2012) Tatiana Barichello et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor
- (2012) Felipe V. Gomes et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol for the treatment ofcannabiswithdrawal syndrome: a case report
- (2012) J. A. S. Crippa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
- (2012) Alline Cristina Campos et al. JOURNAL OF PSYCHIATRIC RESEARCH
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
- (2012) Cristina A J Stern et al. NEUROPSYCHOPHARMACOLOGY
- Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro
- (2012) Benjamin S. Harvey et al. NEUROTOXICOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
- (2012) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
- (2012) Alexandre Rafael de Mello Schier et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
- (2012) M Mecha et al. Cell Death & Disease
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.
- (2011) Gislaine Z. Réus et al. ACTA NEUROPSYCHIATRICA
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
- (2011) Onintza Sagredo et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
- (2011) Toby T Winton-Brown et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress
- (2011) Érica M. Granjeiro et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
- (2011) Antonio Waldo Zuardi et al. PSYCHOPHARMACOLOGY
- Anxiogenic-like effects of chronic cannabidiol administration in rats
- (2011) Maha M. ElBatsh et al. PSYCHOPHARMACOLOGY
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- (2011) Elen V. Fagherazzi et al. PSYCHOPHARMACOLOGY
- Pesquisas com a maconha no Brasil
- (2011) Elisaldo A. Carlini REVISTA BRASILEIRA DE PSIQUIATRIA
- Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
- (2010) Vanessa de Paula Soares et al. BEHAVIOURAL BRAIN RESEARCH
- Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors
- (2010) Plinio C. Casarotto et al. BEHAVIOURAL PHARMACOLOGY
- Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
- (2010) Omar J. Cassol-Jr et al. BRAIN RESEARCH
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
- (2010) I Magen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
- (2010) Y Avraham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
- (2010) Susanne A Wolf et al. Cell Communication and Signaling
- Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol
- (2010) Traute Demirakca et al. DRUG AND ALCOHOL DEPENDENCE
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
- (2010) Felipe V Gomes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
- (2010) Wei Deng et al. NATURE REVIEWS NEUROSCIENCE
- Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience
- (2010) A.C. Campos et al. NEUROSCIENCE
- The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
- (2010) Jaime E.C. Hallak et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
- (2010) Felipe V. Gomes et al. PSYCHOPHARMACOLOGY
- Instituto Nacional de Ciência e Tecnologia em Medicina Translacional (INCT-TM): abordagens metodológicas
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats
- (2009) José Inácio Lemos et al. BEHAVIOURAL BRAIN RESEARCH
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action☆
- (2009) P.J. Lucassen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
- (2009) Paolo Fusar-Poli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
- (2009) Samira S Valvassori et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
- (2009) Alline Cristina Campos et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cannabidiol was ineffective for manic episode of bipolar affective disorder
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
- (2008) J M Bessa et al. MOLECULAR PSYCHIATRY
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
- The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?
- (2008) Gerd Kempermann TRENDS IN NEUROSCIENCES
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation